Plain-English translation of NCT03374267 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that collects information about how doctors treat advanced kidney cancer and bladder cancer in Germany. Researchers will follow patients over 2 to 5 years (depending on cancer type) to understand which treatments are used most often, how treatment plans change over time, and how patients do with their care. The study also measures how the treatments affect quality of life.
Kidney and bladder cancers have many treatment options, but doctors need better information about which treatments work best in real-world practice and how they affect patients' daily lives. This study will help answer those questions and improve future care.
You likely qualify if…
You likely don't qualify if…
You will provide your medical records and information about your cancer diagnosis and treatments to the study team. Researchers will track your care and outcomes over 2 to 5 years depending on your cancer type. If you choose to participate in the quality-of-life portion, you will complete brief questionnaires about how your health is affecting your daily life. You do not need to take any new medication or undergo additional procedures for this study—it simply documents your regular cancer care.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Germany
Sponsor
iOMEDICO AG
Enrollment target
~2,230 participants
Started
December 2017
Primary completion
March 2034
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Michaela Koska
Ludwig Maximilian University of Munich, Dept. of Urology - University Hospital, Munich, Germany
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.